FDA's Deborah Autor to join drugmaker Mylan
(Reuters) - Generic drugmaker Mylan Inc said on Tuesday it hired Deborah Autor, deputy commissioner for global regulatory operations...
Read More »(Reuters) - Generic drugmaker Mylan Inc said on Tuesday it hired Deborah Autor, deputy commissioner for global regulatory operations...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Funding from drug companies and other potential conflicts of interest did not influen...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Certain school-based programs that aim to keep kids from smoking cigarettes seem to ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Neonatal intensive care unit (NICU) interventions for babies born very small and earl...
Read More »(Reuters) - The deadline for health insurers to submit applications to sell insurance in the states in which the Federal government ...
Read More »
WASHINGTON (Reuters) - The Food and Drug Administration has approved an experimental drug from Raptor Pharmaceutical Corp to treat a...
Read More »By Belinda Goldsmith LONDON (Reuters) - More women are going under the knife to achieve the kind of toned upper arms earned by the s...
Read More »(Reuters) - Transition Therapeutics Inc said an early-stage study of its experimental drug for type 2 diabetes showed significant im...
Read More »
(Reuters) - Wrigley's new Alert Energy Caffeine Gum has prompted the U.S. Food and Drug Administration to look into the potential im...
Read More »
By Toni Clarke (Reuters) - Staff reviewers for the Food and Drug Administration have asked a panel of outside medical experts whethe...
Read More »